(VIANEWS) – SPBK1 RINGERIKE (RING.OL), X-FAB (XFAB.PA), REACH SUBSEA (REACH.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SPBK1 RINGERIKE (RING.OL)
21.7% sales growth and 10.56% return on equity
SpareBank 1 Ringerike Hadeland provides various banking products and services to private and corporate customers in Norway. The company offers saving, current, deposit, and currency accounts; vehicle, house and travel, and animal insurance products, as well as life, child, disability, critical illness, accident, health, and business and personal insurance products; mobile and online banking services; and debit and credit cards. It also provides mortgages; car, boat, and other vehicles; consumer and other loans; and bank guarantees, corporate and construction loans, liquidity loans with a government guarantee, and operating credit for agriculture, as well as factoring, leasing, and overdraft services. In addition, the company offers services for buying and selling property; accounting services; pension products; and savings and investment products. The company was founded in 1833 and is based in Hønefoss, Norway.
Earnings Per Share
As for profitability, SPBK1 RINGERIKE has a trailing twelve months EPS of kr27.14.
PE Ratio
SPBK1 RINGERIKE has a trailing twelve months price to earnings ratio of 11.2. Meaning, the purchaser of the share is investing kr11.2 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.56%.
Moving Average
SPBK1 RINGERIKE’s worth is below its 50-day moving average of kr320.32 and under its 200-day moving average of kr323.98.
Volume
Today’s last reported volume for SPBK1 RINGERIKE is 77 which is 71.05% below its average volume of 266.
Yearly Top and Bottom Value
SPBK1 RINGERIKE’s stock is valued at kr304.00 at 22:20 EST, under its 52-week low of kr304.00.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 28.9% and 49.2%, respectively.
More news about SPBK1 RINGERIKE.
2. X-FAB (XFAB.PA)
21.1% sales growth and 13.03% return on equity
X-FAB Silicon Foundries SE operates as an analog/mixed-signal semiconductor technology foundry. The company manufactures silicon wafers for automotive, industrial, consumer, medical, and mobile communications, and other applications; and analog/mixed-signal integrated circuits, sensors, and micro-electro-mechanical systems. It also provides manufacturing and design support services for customers that design analog/mixed-signal integrated circuits and other semiconductor devices, as well as engineering and prototyping, outsourcing, technical, and design support services. The company serves integrated device manufacturers, original equipment manufacturers, and fabless semiconductor companies. It operates in Belgium, Germany, the United Kingdom, Austria, France, Switzerland, Denmark, Sweden, Finland, Netherlands, Ireland, Singapore, China, Japan, Thailand, Malaysia, Korea, Taiwan, Hong Kong, New Zealand, the United States, and internationally. The company was founded in 1992 and is based in Tessenderlo, Belgium.
Earnings Per Share
As for profitability, X-FAB has a trailing twelve months EPS of €0.74.
PE Ratio
X-FAB has a trailing twelve months price to earnings ratio of 14.05. Meaning, the purchaser of the share is investing €14.05 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.03%.
Volume
Today’s last reported volume for X-FAB is 25023 which is 82.03% below its average volume of 139276.
Moving Average
X-FAB’s worth is higher than its 50-day moving average of €10.28 and way higher than its 200-day moving average of €8.57.
Yearly Top and Bottom Value
X-FAB’s stock is valued at €10.40 at 22:20 EST, way below its 52-week high of €11.62 and way higher than its 52-week low of €4.98.
Revenue Growth
Year-on-year quarterly revenue growth grew by 20.3%, now sitting on 807.21M for the twelve trailing months.
More news about X-FAB.
3. REACH SUBSEA (REACH.OL)
19.4% sales growth and 24.57% return on equity
Reach Subsea ASA provides subsea services in Norway and internationally. It operates in two segments, Oil & Gas and Renewable/Other. The company offers inspection, maintenance, and repair services, such as structural inspections, WROV operation, SCM changeout, scale squeeze operations, water injection, ready for operation, subsea equipment maintenance, repair, commissioning, and boulder clearance; and construction support services, including seabed intervention, boulder clearance, touchdown monitoring, and pre-lay and post- lay survey, as well as vessel, remotely operated vehicles, personnel, survey, and on demand engineering. It also provides asset integrity/pipeline inspection, and engineering and project management services; reach remote services comprising survey, inspection, and IMR and seabed intervention; seabed survey services consisting of site surveys and geohazard investigation, pipeline inspection, seabed mapping, UXO, general, and route surveys; offshore cable; marine construction; and rig and mooring services. In addition, the company offers geophysical monitoring services, which include 4D gravity, seafloor subsidence monitoring, depth watch for seismic nodes, injection integrity monitoring, well drilling, and real time seismic monitoring services; and environmental monitoring services that comprise earthquake monitoring and prediction, C02 storage, and geothermal energy exploitation. It serves oil and gas, renewables, and utilities sectors. The company was formerly known as Transit Invest ASA and changed its name to Reach Subsea ASA in December 2012. Reach Subsea ASA was incorporated in 1909 and is headquartered in Haugesund, Norway.
Earnings Per Share
As for profitability, REACH SUBSEA has a trailing twelve months EPS of kr0.67.
PE Ratio
REACH SUBSEA has a trailing twelve months price to earnings ratio of 6.75. Meaning, the purchaser of the share is investing kr6.75 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.57%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 86.7%, now sitting on 1.56B for the twelve trailing months.
More news about REACH SUBSEA.
4. NAVAMEDIC (NAVA.OL)
17.3% sales growth and 10.19% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 26.86. Meaning, the purchaser of the share is investing kr26.86 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.19%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.3%, now sitting on 454.46M for the twelve trailing months.
More news about NAVAMEDIC.
5. BOUVET (BOUV.OL)
9.7% sales growth and 60.9% return on equity
Bouvet ASA provides IT and digital communication consultancy services for public and private sector companies in Norway, Sweden, and internationally. Bouvet ASA was founded in 1995 and is based in Oslo, Norway.
Earnings Per Share
As for profitability, BOUVET has a trailing twelve months EPS of kr3.09.
PE Ratio
BOUVET has a trailing twelve months price to earnings ratio of 18.41. Meaning, the purchaser of the share is investing kr18.41 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 60.9%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 24, 2023, the estimated forward annual dividend rate is 2.5 and the estimated forward annual dividend yield is 4.08%.
Moving Average
BOUVET’s worth is way below its 50-day moving average of kr63.78 and below its 200-day moving average of kr62.05.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.5%, now sitting on 3.22B for the twelve trailing months.
Yearly Top and Bottom Value
BOUVET’s stock is valued at kr56.90 at 22:20 EST, way under its 52-week high of kr70.00 and higher than its 52-week low of kr52.00.
More news about BOUVET.
